|
JPS5328935B2
(enExample)
|
1972-01-20 |
1978-08-17 |
|
|
|
JPS56104333A
(en)
|
1980-01-23 |
1981-08-20 |
Fuji Photo Film Co Ltd |
Color photographic sensitive material
|
|
DE3445669A1
(de)
|
1984-12-14 |
1986-06-19 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
JPS6232459A
(ja)
|
1985-08-05 |
1987-02-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6238463A
(ja)
|
1985-08-14 |
1987-02-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−感光材料の画像形成方法
|
|
JPH067250B2
(ja)
|
1985-10-18 |
1994-01-26 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6292939A
(ja)
|
1985-10-19 |
1987-04-28 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
JPH0756566B2
(ja)
|
1985-11-06 |
1995-06-14 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62129853A
(ja)
|
1985-11-30 |
1987-06-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
JPS62153953A
(ja)
|
1985-12-27 |
1987-07-08 |
Fuji Photo Film Co Ltd |
カラ−写真感光材料
|
|
JPS62173466A
(ja)
|
1986-01-28 |
1987-07-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS62222251A
(ja)
|
1986-02-17 |
1987-09-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62257158A
(ja)
|
1986-04-30 |
1987-11-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
EP0254280B1
(en)
|
1986-07-22 |
1993-12-29 |
Fuji Photo Film Co., Ltd. |
Method for processing silver halide color photographic material
|
|
DE3803775A1
(de)
|
1988-02-09 |
1989-08-17 |
Boehringer Mannheim Gmbh |
Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
JPH02234158A
(ja)
|
1989-03-07 |
1990-09-17 |
Fuji Photo Film Co Ltd |
カラー感光材料
|
|
JPH02264946A
(ja)
|
1989-04-05 |
1990-10-29 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
JPH02267548A
(ja)
|
1989-04-10 |
1990-11-01 |
Fuji Photo Film Co Ltd |
画像形成法
|
|
DE3925584A1
(de)
|
1989-08-02 |
1991-02-07 |
Boehringer Mannheim Gmbh |
Neue n-(dimethyloxophosphinylmethyl-)-lactame, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE4027592A1
(de)
|
1990-08-31 |
1992-03-05 |
Beiersdorf Ag |
Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
|
|
JPH04315148A
(ja)
|
1991-04-15 |
1992-11-06 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
GB9205702D0
(en)
|
1992-03-16 |
1992-04-29 |
Fujisawa Pharmaceutical Co |
A new use of a quinazoline derivative
|
|
EP0598216B1
(en)
|
1992-10-15 |
1997-04-23 |
Fuji Photo Film Co., Ltd. |
Method for processing silver halide color photographic material
|
|
ATE227567T1
(de)
|
1994-05-27 |
2002-11-15 |
Merck & Co Inc |
Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
|
|
US5756502A
(en)
|
1994-08-08 |
1998-05-26 |
Warner-Lambert Company |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
|
|
TW381092B
(en)
*
|
1995-07-07 |
2000-02-01 |
Otsuka Pharma Co Ltd |
Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
|
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
|
US5780480A
(en)
|
1996-02-28 |
1998-07-14 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
EP0885205A4
(en)
|
1996-02-28 |
2002-11-27 |
Merck & Co Inc |
Fibrinogen Receptor Antagonists
|
|
AU6013998A
(en)
|
1996-12-30 |
1998-07-31 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
|
CA2313125A1
(en)
|
1997-12-12 |
1999-06-24 |
Laramie Mary Gaster |
Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
|
|
ATE291011T1
(de)
|
1997-12-22 |
2005-04-15 |
Bayer Pharmaceuticals Corp |
Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
|
|
DE19839499A1
(de)
|
1998-08-29 |
2000-03-02 |
Merck Patent Gmbh |
2-Oxo-2H-chinolinderivate
|
|
AU2001234690A1
(en)
|
2000-02-01 |
2001-08-14 |
Cor Therapeutics, Inc. |
2-(1h)-quinolone and 2-(1h)-quinoxalone inhibitors of factor xa
|
|
JP2002341484A
(ja)
|
2001-03-12 |
2002-11-27 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
JP2002296731A
(ja)
|
2001-03-30 |
2002-10-09 |
Fuji Photo Film Co Ltd |
熱現像カラー画像記録材料
|
|
WO2002090347A1
(en)
|
2001-04-30 |
2002-11-14 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds
|
|
JP2004529943A
(ja)
|
2001-05-15 |
2004-09-30 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー |
殺菌・殺カビ剤としてのピリジニル縮合二環式アミド
|
|
JP2003321472A
(ja)
|
2002-02-26 |
2003-11-11 |
Takeda Chem Ind Ltd |
Ｇｒｋ阻害剤
|
|
EP1388342A1
(en)
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
EP2573079A3
(en)
|
2002-08-23 |
2015-03-11 |
Novartis AG |
Benzimidazole quinolinones and uses thereof
|
|
AU2003272347A1
(en)
|
2002-09-17 |
2004-04-08 |
Merck And Co., Inc. |
Removal of aldehyde impurity by reactive polystyrene resin
|
|
AU2003287880A1
(en)
|
2002-12-11 |
2004-06-30 |
7Tm Pharma A/S |
Cyclic quinoline compounds for use in mch receptor related disorders
|
|
US20040142950A1
(en)
|
2003-01-17 |
2004-07-22 |
Bunker Amy Mae |
Amide and ester matrix metalloproteinase inhibitors
|
|
US7205318B2
(en)
|
2003-03-18 |
2007-04-17 |
Bristol-Myers Squibb Company |
Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
|
|
CN102584813B
(zh)
|
2003-05-14 |
2016-07-06 |
Ngc药物公司 |
化合物及其在调节淀粉样蛋白β中的用途
|
|
CN102174042B
(zh)
|
2003-05-19 |
2013-09-18 |
Irm有限责任公司 |
免疫抑制剂化合物和组合物
|
|
JP4823914B2
(ja)
|
2003-11-07 |
2011-11-24 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
Ｆｇｆｒ３の阻害および多発性骨髄腫の治療
|
|
WO2005087742A1
(en)
|
2004-03-08 |
2005-09-22 |
Exelixis, Inc. |
Metabolic kinase modulators and methods of use as pesticides
|
|
WO2005094805A1
(ja)
|
2004-04-01 |
2005-10-13 |
Institute Of Medicinal Molecular Design. Inc. |
イミン誘導体及びアミド誘導体
|
|
EP1758899A1
(en)
|
2004-06-03 |
2007-03-07 |
Brandeis University |
Asymmetric michael and aldol addition using bifunctional cinchona-alkaloid-based catalysts
|
|
GB0416730D0
(en)
|
2004-07-27 |
2004-09-01 |
Novartis Ag |
Organic compounds
|
|
EP1655295A1
(en)
|
2004-11-03 |
2006-05-10 |
Schering Aktiengesellschaft |
Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
|
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
|
US20060281763A1
(en)
|
2005-03-25 |
2006-12-14 |
Axon Jonathan R |
Carboxamide inhibitors of TGFbeta
|
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
|
WO2006130437A2
(en)
|
2005-05-27 |
2006-12-07 |
Brandeis University |
Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
|
|
BRPI0616338A2
(pt)
|
2005-09-23 |
2011-06-14 |
Coley Pharm Group Inc |
mÉtodo para 1h-imidazo[4,5-c] piridinas e anÁlogos da mesma
|
|
EP1984354B1
(en)
|
2006-02-16 |
2009-08-05 |
Syngeta Participations AG |
Pesticides containing a bicyclic bisamide structure
|
|
GB0605689D0
(en)
|
2006-03-21 |
2006-05-03 |
Novartis Ag |
Organic compounds
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
EP2023926B1
(en)
|
2006-05-19 |
2011-10-12 |
Bayer Pharma Aktiengesellschaft |
Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
|
|
WO2008029152A2
(en)
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
US9987277B2
(en)
|
2006-10-04 |
2018-06-05 |
Janssen Sciences Ireland Uc |
Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
CA2676173A1
(en)
|
2007-02-16 |
2008-08-28 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
|
|
AU2008223348A1
(en)
*
|
2007-03-07 |
2008-09-12 |
Alantos Pharmaceuticals Holding, Inc. |
Metalloprotease inhibitors containing a heterocyclic moiety
|
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
|
JP2008280341A
(ja)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物およびその防除用途
|
|
EP2147310A4
(en)
|
2007-04-27 |
2010-09-08 |
Univ Rochester |
COMPOSITIONS AND METHODS OF INHIBITING G-PROTEIN SIGNALING
|
|
EP2008658A1
(en)
|
2007-06-28 |
2008-12-31 |
Bayer Schering Pharma Aktiengesellschaft |
Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
|
|
AR070027A1
(es)
|
2007-09-17 |
2010-03-10 |
Abbott Lab |
Agentes anti-infecciosos contra el virus hcv
|
|
EA201001847A1
(ru)
|
2008-06-11 |
2011-08-30 |
Айрм Ллк |
Соединения и композиции, применяемые для лечения малярии
|
|
US20100068204A1
(en)
|
2008-09-12 |
2010-03-18 |
Wyeth |
4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
|
|
WO2010045374A1
(en)
|
2008-10-15 |
2010-04-22 |
Gilead Palo Alto, Inc. |
3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
|
|
JP5478637B2
(ja)
*
|
2008-12-23 |
2014-04-23 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｐ２ｘ７モジュレーターとしてのジヒドロピリドンアミド
|
|
CA2754058A1
(en)
|
2009-03-02 |
2010-09-10 |
Sirtris Pharmaceuticals, Inc. |
8-substituted quinolines and related analogs as sirtuin modulators
|
|
US8278302B2
(en)
*
|
2009-04-08 |
2012-10-02 |
Boehringer Ingelheim International Gmbh |
Substituted piperidines as CCR3 antagonists
|
|
US8362249B2
(en)
|
2009-04-27 |
2013-01-29 |
Boehringer Ingelheim International Gmbh |
CXCR3 receptor antagonists
|
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
|
CA2779355C
(en)
*
|
2009-11-05 |
2018-01-16 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
US20130109672A1
(en)
|
2010-04-29 |
2013-05-02 |
The United States Of America,As Represented By The Secretary, Department Of Health And Human Service |
Activators of human pyruvate kinase
|
|
JP5960688B2
(ja)
|
2010-05-17 |
2016-08-02 |
インコゼン セラピューティクス プライベート リミテッド |
プロテインキナーゼ調節物質としての新規３，５−二置換−３ｈ−［１，２，３］トリアゾロ［４，５−ｂ］ピリジン化合物
|
|
WO2011156632A2
(en)
|
2010-06-09 |
2011-12-15 |
Georgetown University |
Compositions and methods of treatment for tumors in the nervous system
|
|
US20130137865A1
(en)
|
2010-08-11 |
2013-05-30 |
Taisho Pharmaceutical Co., Ltd. |
Heteroaryl-pyrazole derivative
|
|
AR084070A1
(es)
*
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
CA2817460A1
(en)
|
2010-12-17 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
|
|
TW201309639A
(zh)
|
2011-02-17 |
2013-03-01 |
Lg Life Sciences Ltd |
作為ｇｐｒ１１９促效劑之肟衍生物
|
|
WO2012125668A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
GB201106743D0
(en)
*
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106750D0
(en)
*
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
JP5742439B2
(ja)
|
2011-05-02 |
2015-07-01 |
信越化学工業株式会社 |
蛍光性化合物及び蛍光性樹脂組成物
|
|
JP6007417B2
(ja)
|
2011-05-31 |
2016-10-12 |
レセプトス エルエルシー |
新規ｇｌｐ−１受容体安定剤および調節剤
|
|
CN102887895B
(zh)
|
2011-07-22 |
2016-08-24 |
山东轩竹医药科技有限公司 |
吡啶并嘧啶类mTOR抑制剂
|
|
US20140315881A1
(en)
|
2011-07-29 |
2014-10-23 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
IN2014CN02806A
(enExample)
*
|
2011-10-14 |
2015-07-03 |
Bristol Myers Squibb Co |
|
|
EP2770993A2
(en)
|
2011-10-26 |
2014-09-03 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Method of treating hcv infection with a small molecule chk2 inhibitor
|
|
IN2014MN01982A
(enExample)
|
2012-04-25 |
2015-07-10 |
Raqualia Pharma Inc |
|
|
JPWO2014034719A1
(ja)
|
2012-08-29 |
2016-08-08 |
興和株式会社 |
Ｔｌｒ阻害作用を有するキノリン誘導体
|
|
JP2016504990A
(ja)
|
2012-12-20 |
2016-02-18 |
バイエル ファーマ アクチエンゲゼルシャフト |
Ｂｅｔタンパク質抑制性ジヒドロピリドピラジノン
|
|
HK1211033A1
(en)
|
2012-12-20 |
2016-05-13 |
Bayer Pharma Aktiengesellschaft |
Bet-protein-inhibiting dihydroquinoxalinones
|